`
`Exhibit W
`
`Genome Exhibit 1061
`
`Page 1 of 6
`
`Genome Exhibit 1061
`Page 1 of 6
`
`
`
`5/13/2019
`
`Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found... | Esmo Open
`
`We use cookies to improve our service and to tailor our content and advertising to you. More info
`
`BARGELDNA Mungmss
`
`2919
`
`
`
`
`
`
`Register now!
`
`_
`
`.
`
`_
`
`I
`
`+
`
`.
`
`MDpen $7.35...
`
`Home
`
`Archive
`
`Volume2,lssue1
`
`<1
`
`Article info
`
`Article menu
`
`Editorial
`
`1506
`
`Immune checkpoint inhibitors in lung cancer: the holy grail
`has not yet been found...
`
`Check klr
`updates
`
`Authors
`
`Satheesh Thungappa
`
`Phase | Early Clinical Trials Unit, Department ofOncology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium
`
`PubMed articles
`
`Google scholar articles
`
`Jose Ferri
`
`Phase I Early Clinical Trials Unit, Department ofOncology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium
`
`Consorci Hospital General Universitari de Valencia, Valencia, Comunitat Valenciana, Spain
`
`PubMed articles
`
`Google scholar articles
`
`Full Text
`
`Christian Caglevic
`Early Development Drugs Unit, Medical Oncology Department, lnstituto Oncologico Fundacién Arturo Lopez Perez,
`
`Help
`
`Santiago, Chile
`
`PubMed articles
`
`Google scholar articles
`
`Francesco Passiglia
`
`Phase I Early Clinical Trials Unit, Department ofOncology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium
`
`Department of Oncology, Universita degli Studi di Palermo, Palermo, Sicilia, Italy
`
`PubMed articles
`
`Google scholar articles
`
`Luis Raez
`
`Thoracic Oncology Program, Memorial Cancer Institute, Memorial Health Care System, Pembroke Pines, Florida, USA
`
`PubMed articles
`
`Google scholar articles
`
`https://esmoopen.bmj.com/content/2/1/e000162.info
`
`Genome Exhibit 1061
`Page 2 of 6
`
`1/5
`
`Genome Exhibit 1061
`Page 2 of 6
`
`
`
`
`
`5/13/2019
`
`Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found... | Esmo Open
`
`bmjcarzeers
`
`Consultant Clinical Oncologist — Breast/Sarcoma
`Lothian
`£80653.00 to £107170.00
`
`Due to the scale of this expansion, a number of new posts will be advertised over the coming months
`Recruiter: NHS Lothian
`
`Apply for this job
`
`Consultant Clinical Oncologist
`Lothian
`£80653.00 to £107170.00
`
`Due to the scale of this expansion, a number of new posts will be advertised over the coming months
`Recruiter: NHS Lothian
`
`Apply for this job
`
`Consultant Post in Clinical Oncology(10 sessions) Head & Neck + Upper Gl/Urology
`Dundee, Dundee City
`£80,653 - £107,170
`
`An excellent opportunity has arisen to work in Tayside Cancer Centre.
`
`Recruiter: NHS Tayside
`
`Apply for this job
`
`Consultant Medical Oncologists for Sarcoma
`London (Central), London (Greater)
`£77,913 to £105,042 pa
`
`You will join an experienced team of medical, clinical and paediatric oncologists
`
`Recruiter: University College London Hospitals NHS Foundation Trust
`
`A_4__l__ 2__LI_:_ :_|_
`
`Other content recommended for you
`
`ESMO Copenhagen 2016: a lung cancer ‘grand cru’
`Jean-Yves Douillard et al., ESMO open, 2017
`
`FullText
`
`Help
`-'
`
`ls smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced
`
`non-small cell lung cancer?
`
`Robert Pirker, ESMO open, 2018
`
`30 Immunotherapy in advanced NSCLC—from the ‘tsunami’ of therapeutic knowledge to a clinical
`
`practice algorithm: results from an international expert panel meeting of the Italian Association of
`
`Thoracic Oncology (AIOT)
`
`Filippo de Marinis et al., ESMO open, 2018
`
`Targeting immune checkpoints in breast cancer: an update of early results
`
`Cinzia Solinas et al., ESMO open, 2017
`
`Nivolumab for NSCLC in Japanese patients: similar benefits, but beware of pneumonitis
`Genome Exhibit 1061
`
`htt s://esmoo en.bm'.com/content/2/1/e000162.info
`p
`p
`J
`
`Page 4 of 6
`
`3/5
`
`Genome Exhibit 1061
`Page 4 of 6
`
`
`
`5/13/2019
`
`Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found... | Esmo Open
`
`Johan Vansteenkiste, ESMO open, 2017
`
`Into the Clinic With Nivolumab and Pembrolizumab.
`
`Catherine A Shu et al., Oncologist, 2016
`
`Immunotherapy: Promising results in first and second line treatment of metastatic bladder cancer
`
`MedicalXpress
`
`V
`
`
`
` GDDD SCIENCE
`
`
`
`‘I.
`
`3M0
`mammals:
`
`
`BETTER MEDICINE
`BEST menu:
`
`\‘t
`3+:
`. * ..
`
`8M0
`
`.mm, M“ .....
`
`CONTENT
`
`Latest content
`
`Archive
`
`Most read articles
`
`Responses
`
`JOURNAL
`
`About
`
`Editorial policies
`
`Editorial board
`
`Thank you to our reviewers
`
`Sign up for email alerts
`
`AUTHORS
`
`Instructions for authors
`
`Full Text
`
`Help
`
`htt s://esmoo en.bm'.com/content/2/1/e000162.info
`p
`p
`J
`
`Genome Exhibit 1061
`
`4/5
`
`Page 5 of 6
`
`Genome Exhibit 1061
`Page 5 of 6
`
`
`
`5/13/2019
`
`Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found... | Esmo Open
`
`Submit an article
`
`FAQs
`
`Open Access at BMJ
`
`BMJ Author Hub
`
`HELP
`
`Contact us
`
`Reprints
`
`Permissions
`
`Advertising
`
`Feedback form
`
`R g f «mull.
`
`B MJ
`
`Website Terms & Conditions
`
`Privacy & Cookies
`
`Contact BMJ
`
`Online: ISSN 2059-7029
`
`Copyright © 2018 European Society for Medical Oncology
`
`filCP§15042040%‘-3
`
`Learn more today p
`
`Journal Of
`Medical GEI'IBtiCS
`BM]
`
`Keep up to date with the lateet
`advances in genetic medicine
`
`htt s://esmoo en.bm'.com/content/2/1/e000162.info
`p
`p
`J
`
`Genome Exhibit 1061
`
`5/5
`
`Page 6 of 6
`
`Genome Exhibit 1061
`Page 6 of 6
`
`